2H
2HCA.AS iShares MSCI World Health Care Sector ESG UCITS ETF USD Acc EUR
5.71 EUR
Close of Oct 29, 2026
4.43
5.71
- Total assets
- 486M
- Expense ratio
- 0.18%
- Dividend yield
- -
- 1-year return
- -2.36%
- Holdings
- 10
- Since
- 2021
Fund data as reported by the issuer, updated Oct 28, 2026. Total assets are in the fund's base currency.
What does 2HCA.AS invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (67.7%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (69.5%)
- Top 3 holdings: 20.6% of the fund
Asset allocation
- US stocks 67.7%
- Non-US stocks 28.8%
- Cash 0.5%
Top holdings
- Eli Lilly and Company 10.57%
- AbbVie Inc 5.11%
- Novartis AG 4.87%
- Johnson & Johnson 4.44%
- AstraZeneca PLC 4.00%
iShares MSCI World Health Care Sector ESG UCITS ETF USD Acc EUR performance
Sharpe ratio 0.22- This year
- +11.01%
- 1 year
- -2.36%
- 3 years
- +0.16%
- 5 years
- 0.00%
Volatility 14.1% over 1 year and 13.5% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
2HCA.AS price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
iShares MSCI World Health Care Sector ESG UCITS ETF USD Acc EUR top holdings
42.4% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Eli Lilly and Company LLY.US | Healthcare | United States | 10.57% |
| AbbVie Inc ABBV.US | Healthcare | United States | 5.11% |
| Novartis AG NOVN.SW | Healthcare | Switzerland | 4.87% |
| Johnson & Johnson JNJ.US | Healthcare | United States | 4.44% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 4.00% |
| UnitedHealth Group Incorporated UNH.US | Healthcare | United States | 3.30% |
| Merck & Company Inc MRK.US | Healthcare | United States | 2.73% |
| Roche Holding AG ROG.SW | Healthcare | Switzerland | 2.69% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 2.52% |
| Novo Nordisk A/S NOVO-B.CO | Healthcare | Denmark | 2.18% |
2HCA.AS sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
2HCA.AS regional exposure
- North America69.5%
- Europe Developed18.0%
- United Kingdom4.7%
- Japan3.7%
- Australasia0.8%
- Africa/Middle East0.1%
Share of the stocks in the fund.
Company size
Average market cap 149B- Mega cap27.6%
- Big cap43.5%
- Medium cap25.3%
- Small cap0.6%
iShares MSCI World Health Care Sector ESG UCITS ETF USD Acc EUR fund profile
- Fund name
- iShares MSCI World Health Care Sector ESG UCITS ETF USD Acc EUR
- Ticker
- 2HCA.AS
- Exchange
- Euronext Amsterdam
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Nov 1, 2021
- Trading currency
- EUR
- Expense ratio
- 0.18%